ANADIN ANALGESIC
Country: Ireland
Language: English
Source: HPRA (Health Products Regulatory Authority)
Summary of Product characteristics
(SPC)
30-04-2024
Some documents for this product are not currently available, you can send a request to our customer service and we will notify you as soon as we are able to obtain them.
Send request.
Send request.
Active ingredient:
ACETYLSALICYLIC ACID CAFFEINE QUININE SULFATE
Available from:
Pfizer Consumer Healthcare Ltd
Dosage:
325/15/1 Milligram
Pharmaceutical form:
Film Coated Tablet
Authorization date:
1983-01-10
Summary of Product characteristics
SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE MEDICINAL PRODUCT
Anadin Analgesic Film-coated Tablets
Aspirin 325mg
Caffeine 15mg
Quinine Sulphate 1mg
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
Each tablet contains;
For a full list of excipients, see section 6.1.
3 PHARMACEUTICAL FORM
White capsule shaped, film coated tablets (tablets) debossed on both faces with ‘ANADIN’.
4 CLINICAL PARTICULARS
4.1 THERAPEUTIC INDICATIONS
For the relief of pain of headache, neuralgia, rheumatic pain, period pain, dental pain, toothache, and the relief of
symptoms of the common cold.
4.2 POSOLOGY AND METHOD OF ADMINISTRATION
Oral
ADULTS AND ADOLESCENTS OVER 16 YEARS: Take 2 tablets every 4 hours if necessary. Do not exceed 12 tablets in any 24
hour period.
Do not give to children and adolescents aged under 16 years, except on medical advice, where the benefit outweighs
the risk.
ELDERLY: Non-steroidal anti-inflammatory drugs should be used with particular caution in elderly patients who are more
prone to adverse events. The lowest dose compatible with adequate safe clinical control should be employed. See also
Section 4.4.
4.3 CONTRAINDICATIONS
Patients with a history of hypersensitivity reactions (e.g. bronchospasm, rhinitis, urticaria) in response to Anadin
Analgesic Film-coated Tablets, aspirin or other non-steroidal anti-inflammatory drugs or any of the other constituents.
Children and adolescents under 16 years.
Breast-feeding.
Last-trimester of pregnancy.
Concurrent anti-coagulant therapy.
Patients with severe renal failure.
Acetylsalicylic acid (aspirin)
325.0 mg
Caffeine
15.0 mg
Quinine Sulphate
1.0 mg
IRISH MEDICINES BOARD
________________________________________________________________________________________________________________________
_Date Printed 14/02/2011_
_CRN 2094958_
_page number: 1_
Intake of more than
Read the complete document
